Low 25OH vitamin D2 levels found in untreated Alzheimer's patients, compared to acetylcholinesterase-inhibitor treated and controls

Current Alzheimer Research

Volumn 9, Issue 9, 2012, Pages 1069-1076

  Shah, Iltaf ^a   Petroczi, Andrea ^a   Tabet, Naji ^b,c   Klugman, Anthony ^c   Isaac, Mokhtar ^c   Naughton, Declan P ^a  

^a KINGSTON UNIVERSITY   (United Kingdom)

^b BRIGHTON AND SUSSEX MEDICAL SCHOOL   (United Kingdom)

^c SUSSEX PARTNERSHIP NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Acetylcholinesterase inhibitor; Alzheimer's disease; ICP MS; Insufficiency; LC MS MS; Vitamin D2

Indexed keywords

25 HYDROXYERGOCALCIFEROL; DONEPEZIL; GALANTAMINE; RIVASTIGMINE;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; COGNITION; CONTROLLED STUDY; FEMALE; HUMAN; LIQUID CHROMATOGRAPHY; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; PRIORITY JOURNAL; TANDEM MASS SPECTROMETRY; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; CHOLINESTERASE INHIBITORS; CHROMATOGRAPHY, LIQUID; ERGOCALCIFEROLS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; TANDEM MASS SPECTROMETRY; VITAMIN D DEFICIENCY;

EID: 84870194078     PISSN: 15672050     EISSN: 18755828     Source Type: Journal    
DOI: 10.2174/156720512803568975     Document Type: Article

References (45)

1. Zhang R, Naughton DP. Vitamin D in health and disease: Current Perspectives. Nutr J 9: 65 (2010).
2. Holick MF. Sunlight and Vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. Am J Clin Nutr 80(6): 1678S-1688S (2004).
3. Melamed ML, Muntner P, Michos ED, Uribarri J, Weber C, Sharma J, et al. Serum 25-hydroxyvitamin D levels and the prevalence of peripheral arterial disease: results from NHANES 2001 to 2004. Arterioscler Throm Vasc Biol 28: 1179-1185 (2008).
4. Institute of Medicine, Food and Nutrition Board. Dietary Reference Intakes for Calcium and Vitamin D. National Academy Press: Washington, DC (2010).
5. Webb AR, Kline L, Holick MF. Influence of season and latitude on the cutaneous synthesis of vitamin D3: Exposure to winter sunlight in Boston and Edmonton will not promote vitamin D3 synthesis in human skin. J Clin Endocrinol Metab 67: 373-378 (1988).
6. Buell JS, Hughes-Dawson B, Scott TM, Weiner DE, Dallal GE, Qui WQ, et al. 25-Hydroxyvitamin D, dementia, and cerebrovascular pathology in elders receiving home services. Neurology 74: 18-26 (2010).
7. Annweiler C, Schott AM, Allali G, Bridenbaugh SA, Kressig RW, Allain P, et al. Association of vitamin D deficiency with cognitive impairment in older women: Cross-sectional study. Neurology 74: 27-32 (2010).
8. Llewellyn DJ, Lang IA, Langa KM, Melzer D. Vitamin D and cognitive impairment in the elderly U.S. population. Gerontol A Biol Sci Med Sci 166A: 59-65 (2010).
9. Przybelski RJ, Binkley NC. Is vitamin D important for preserving cognition? A positive correlation of serum 25-hydroxyvitamin D concentration with cognitive function. Arch Biochem Biophys 460: 202-205 (2007).
10. Tolppanen A-M, Williams DM, Lawlor DA. The association of serum ionized calcium and vitamin D with adult cognitive performance. Epidemiology 22: 113-117 (2011).
11. Llewellyn DJ, Lang IA, Langa KM, Muniz-Terrera G, Phillips CL, Cherubini A, et al. Vitamin D and risk of cognitive decline in elderly persons. Arch Intern Med 170: 1135-1141 (2010).
12. McGrath J, Scragg R, Chant D, Eyles D, Burne T, Obradovic D. No association between serum 25-hydroxyvitamin D3 level and performance on psychometric tests in NHANES III. Neuroepidemiology 29: 49-54 (2007).
13. Slinin Y, Paudel ML, Taylor BC, Fink HA, Ishani A, Candles MT, et al. Osteoporotic Fractures in Men (MrOS) Study Research Group 25-Hydroxyvitamin D levels and cognitive performance and decline in elderly men. Neurology 74: 33-41 (2010).
14. Annweiler C, Allali G, Allain P, Bridenbaugh S, Schott AM, Kressig RW, et al. Vitamin D and cognitive performance in adults: a systematic review. Eur J Neurol 16: 1083-1089 (2009).
15. Shah I, James R, Barker J, Petroczi A, Naughton DP. Misleading measures in Vitamin D analysis: A novel LC-MS/MS assay to account for epimers and isobars. Nutr J 10: 46 (2011).
16. Carter GD, Carter R, Jones J, Berry J. How accurate are assays for 25-hydroxyvitamin D? Data from the international vitamin D external quality assessment scheme. Clin Chem 50: 2195-2197 (2004).
17. Binkley N, Krueger D, Gemar D, Drezner MK. Correlation among 25-hydroxyvitamin D assays. J Clin Endocrinol Metab 93: 1804-1808 (2008).
18. Nes M, Sem SW, Rousseau B, Bjørneboe GE, Engedal K, Trygg K, et al. Dietary intakes and nutritional status of old people with dementia living at home in Oslo. Eur J Clin Nutr 42: 581-593 (1988).
19. Ascherio A, Munger KL, Simon KC. Vitamin D and multiple sclerosis. Lancet Neurol 9: 599-612 (2010).
20. Folstein MF, Folstein SE, McHugh PR. Mini-mental state: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12: 189-198 (1975).
21. Van den Ouweland JM, Beijers AM, Demacker PN, Van Daal H. Measurement of 25-OH-vitamin D in human serum using liquid chromatography tandem-mass spectrometry with comparison to radioimmunoassay and automated immunoassay. J Chromatogr B 878: 1163-1168 (2010).
22. Hodkinson HM. Evaluation of a mental test score for assessment of mental impairment in the elderly. Age Ageing 1: 233-238 (1972).
23. Dhesi JK, Jackson SH, Bearne LM, Moniz C, Hurley MV, Swift CG, et al. Vitamin D supplementation improves neuromuscular function in older people who fall. Age Ageing 33: 589-595 (2004).
24. Przybelski R, Agrawal S, Krueger D, Engelke JA, Walbrun F, Binkley N. Rapid correction of low vitamin D status in nursing home residents. Osteoporos Int 19: 1621-1628 (2008).
25. Joint position statement issued to provide vitamin D clarity. [http://info.cancerresearchuk.org/news/archive/cancernews/2010-12-16-Joint-position-statement-issued-to-provide-vitamin-Dclarity-?rss=true].
26. Holick MF. Vitamin D status: Measurement, interpretation, and clinical application. Ann Epidemiol 19: 73-78 (2009).
27. Dietary Supplement Fact Sheet: Vitamin D. [http://ods.od.nih.gov/factsheets/vitamind].
28. Pearce SHS, Cheetham TD. Diagnosis and management of vitamin D deficiency. BMJ 340: b5664 (2010).
29. Willett AM. Vitamin D status and its relationship with parathyroid hormone and bone mineral status in older adolescents. Proc Nutr Soc 64: 193-203 (2005).
30. Lanham-New S. Vitamin D in the spotlight--time for urgent action? Br J Nutr 104: 315-317 (2010).
31. Bischoff-Ferrari HA, Giovannucci E, Willett WC, Dietrich T, Dawson-Hughes B. Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr 84: 18-28 (2006).
32. Dawson-Hughes B, Heaney RP, Holick MF, Lips P, Meunier PJ, Vieth R. Estimates of optimal vitamin D status. Osteoporos Int 16: 713-716 (2005).
33. Rhodes LE, Webb AR, Fraser HI, Kift R, Durkin MT, Allan D, et al. Recommended summer sunlight exposure levels can produce sufficient (>/=20 ng ml(-1)) but not the proposed optimal (>/=32 ng ml(-1)) 25(OH)D levels at UK latitudes. J Invest Dermatol 130: 1411-1418 (2010).
34. Hollis BW. Comparison of equilibrium and disequilibrium assay conditions for ergocalciferol, cholecalciferol and their metabolites. J Steroid Biochem 21: 81-86 (1984).
35. Jones G. Analog metabolism. In: (Eds: Feldman D, Glorieux F, Pike JW). Vitamin D. New York, NY: Elsevier Academic Press pp. 973-994 (1997).
36. Rapuri PB, Gallagher JC, Haynatzki G. Effect of vitamins D2 and D3 supplement use on serum 25OHD concentration in elderly women in summer and winter. Calcified Tissue Int 74: 150-156 (2004).
37. Hartwell D, Hassager C, Christiansen C. Effect of Vitamin D2 and Vitamin D3 on the serum concentrations of 1,25(OH)2D2 and 1,25(OH)2D3 in normal subjects. Acta Endocrinol (Copenh) 115: 378-384 (1987).
38. Tjellesen L, Hummer L, Christiansen C, Rodbro P. Serum concentration of vitamin D metabolites during treatment with vitamin D2 and D3 in normal premenopausal women. Bone Miner 1: 407-413 (1986).
39. Armas LA, Hollis BW, Heaney RP. Vitamin D2 is much less effective than vitamin D3 in humans. J Clin Endocrinol Metab 89: 5387-5391 (2004).
40. Holmberg I, Berlin T, Ewerth S, Bjorkhem I. 25-Hydroxylase activity in subcellular fractions from human liver. Evidence for different rates of mitochondrial hydroxylation of vitamin D2 and D3. Scand J Clin Lab Invest 46: 785-790 (1986).
41. Cheng JB, Motola DL, Mangelsdorf DJ, Russell DW. Deophanization of cytochrome P450 2R1. A microsomal vitamin D 25-hydroxylase. J Biol Chem 278: 38084-38093 (2003).
42. Cheng JB, Levine MA, Bell NH, Mangelsdorf DJ, Russell DW. Genetic evidence that the human CYP2R1 enzyme is a key vitamin D 25-hydroxylase. Proc Natl Acad Sci USA 101: 7711-7715 (2004).
43. Bailey JA, Ray B, Greig NH, Lahiri DK. Rivastigmine lowers Aβ and increases sAPPα levels, which parallel elevated synaptic markersand metabolic activity in degenerating primary rat neurons. PLoS One 6:e21954 (2011).
44. Tabet N. Acetylcholinesterase inhibitors for Alzheimer's disease: anti-inflammatories in acetylcholine clothing! Age Ageing 35: 336-338 (2006).
45. Sterne J, Gavaghan D, Egger M. Publication and related bias in meta-analysis: Power of statistical tests and prevalence in literature. J Clin Epidemiol 53:1119-1119 (2000).